ClinicalTrials.gov
ClinicalTrials.gov Menu

Resistance Training in Elderly

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00744094
Recruitment Status : Completed
First Posted : August 29, 2008
Last Update Posted : September 23, 2015
Sponsor:
Collaborators:
The Anna Foundation
DSM Food Specialties
Information provided by:
Maastricht University Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
In the present study the investigators aim to determine whether protein supplementation can augment the response to a 12 week resistance training program in healthy elderly men.

Condition or disease Intervention/treatment Phase
Sarcopenia Atrophy Aging Dietary Supplement: protein drink Behavioral: Resistance training Phase 1 Phase 2

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Influence of Resistance Training on Body Composition and Muscle Characteristics in Healthy Elderly
Study Start Date : January 2007
Actual Primary Completion Date : September 2007
Actual Study Completion Date : July 2008
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Placebo Comparator: 1
placebo drink
 Behavioral: Resistance training
12 weeks resistance training, 3 days per week
Experimental: 2
protein drink
 Dietary Supplement: protein drink
250 ml protein hydrolysate solution

Behavioral: Resistance training
12 weeks resistance training, 3 days per week


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Muscle mass measured at limb and cellular level [ Time Frame: before and after 12 weeks of intervention ]

Secondary Outcome Measures :
  1. Muscle strength [ Time Frame: before and after 12 weeks of intervention ]
  2. Body composition [ Time Frame: before and after 12 weeks of intervention ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years to 85 Years   (Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Living independently

Exclusion Criteria:

  • Diabetes
  • Cardiovascular disease
  • Orthopedic limitations
  • Any disorder known to compromise ability for resistance training
  • History of resistance training in past 5 years
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00744094


Locations
Netherlands
Maastricht University
Maastricht, Netherlands, 6200MD
Sponsors and Collaborators
Maastricht University Medical Center
The Anna Foundation
DSM Food Specialties
Investigators
Principal Investigator: Luc JC van Loon, PhD Maastricht University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Dr. L. van Loon, Maastricht University
ClinicalTrials.gov Identifier: NCT00744094     History of Changes
Other Study ID Numbers: MEC 06-3-062B
First Posted: August 29, 2008    Key Record Dates
Last Update Posted: September 23, 2015
Last Verified: August 2008

Keywords provided by Maastricht University Medical Center:
resistance training
protein supplementation
hypertrophy

Additional relevant MeSH terms:
Atrophy
Sarcopenia
Pathological Conditions, Anatomical
Muscular Atrophy
 Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms